Rhovica Neuroimaging AG
PrivateLast Round
Grant
Jan 22, 2026
Total Funding Raised
$3.08M
Company Overview
Rhovica Neuroimaging AG operates in Healthcare & Life Sciences and is based in Bern. Its latest recorded funding round was a Grant round in January 2026.
Rhovica Neuroimaging AG is a medical technology company that develops the SoNav system, a bedside navigation platform for the safe and precise placement of external ventricular drainage catheters in neurocritical care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Sensors, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhovica Neuroimaging AG Comparables
Compare Rhovica Neuroimaging AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| inTRAvent Medical Partners | 87% | |
| Luciole Medical AG | 73% | |
| Tokibo Co., Ltd. | 73% |
For institutional investors. Book with your work email.
Rhovica Neuroimaging AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2026 | ||||
| Pre Seed | Aug 26, 2025 | ||||
| Grant | Sep 13, 2024 | ||||
| Grant | Dec 12, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rhovica Neuroimaging AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Pre Seed |
| ValueMaker AG | Pre Seed |
| M2care | Pre Seed |
| Venture Kick | Grant |
| Ypsomed Innovation Fund Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Grew 150% QoQ, from 2 to 5 employees.
- Aug 26, 2025
Carsten Laue joins the Board of Directors.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 28, 2026
Rhovica Neuroimaging AG is developing the SoNav(TM) platform in Switzerland to give neurosurgeons real-time anatomical vision through guidance and monitoring integrated into neurosurgical instruments; its first product uses a miniaturized sensor array in a brain catheter for real-time guided bedside placement in an emergency procedure.
For institutional investors. Book with your work email.
Rhovica Neuroimaging AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rhovica Neuroimaging AG's valuation, stock price, and market status.
Is Rhovica Neuroimaging AG a public or private company?
Rhovica Neuroimaging AG is a private company.
What is the current stock price of Rhovica Neuroimaging AG?
Rhovica Neuroimaging AG is a private company, so its shares have no public market price. Caplight tracks Rhovica Neuroimaging AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rhovica Neuroimaging AG worth (valuation)?
Valuation information for Rhovica Neuroimaging AG is not publicly available.
Can I buy Rhovica Neuroimaging AG stock?
Rhovica Neuroimaging AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rhovica Neuroimaging AG's last funding round?
Rhovica Neuroimaging AG's most recent funding round was Grant on January 22, 2026.
Who are the main investors in Rhovica Neuroimaging AG?
Key investors in Rhovica Neuroimaging AG include M2care.
Will Rhovica Neuroimaging AG IPO soon?
No public IPO plans have been announced for Rhovica Neuroimaging AG.
How can I track Rhovica Neuroimaging AG secondary market activity?
Caplight tracks bids, offers, and trades in Rhovica Neuroimaging AG's shares on secondary markets.